Pluristem Therapeutics to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference

NEW YORK--(BUSINESS WIRE)--Pluristem Therapeutics Inc. (NASDAQ:PSTI) (DAX:PJT), a bio-therapeutics company dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for a variety of degenerative, ischemic and autoimmune indications, today announced that the Company will present at the Rodman & Renshaw 5th Annual Global Healthcare Conference in Monte Carlo, Monaco on May 20, 2008, 3:00 a.m. EDT (9:00 a.m. Central European Summer Time). Zami Aberman, Pluristem’s Chairman, President and Chief Executive Officer, will be presenting.